cancer

VECTIBIX® (panitumumab) Injection

Vectibix is an epidermal growth factor receptor (EGFR) antagonist indicated for the treatment of wild-type RAS (defined as wild-type in both KRAS and NRAS as determined by an FDA-approved test for this use) metastatic colorectal cancer (mCRC)

SUTENT® (sunitinib malate) capsules

Sunitinib is a kinase inhibitor present in SUTENT capsules as the malate salt. Sunitinib is a small molecule that inhibits multiple receptor tyrosine kinases (RTKs), some of which are implicated in tumor growth, pathologic angiogenesis, and metastatic progression of cancer.

YONSA- abiraterone acetate tablet

Abiraterone acetate, the active ingredient of YONSA tablet is the acetyl ester of abiraterone. YONSA is indicated in combination with methylprednisolone for the treatment of patients with metastatic castration-resistant prostate cancer.